Green Relief

FEBRUARY 19, 2018

Luckily there are knowledgeable medical nutrigenomic practitioners (like myself) who are able to advise how to decrease this methylation/cannabis pediatric risk factor, through genetic screening that is accessible to most everyone. Accessed online at: [link]. Piomeli, Daniele (2002). 2002 Feb-Mar;66(2-3):143-60.

Therapy 40

Therapy Cannabinoids Terpenes Pharmaceutical 40

Green Relief

FEBRUARY 20, 2018

Luckily there are knowledgeable medical nutrigenomic practitioners (like myself) who are able to advise how to decrease this methylation/cannabis pediatric risk factor, through genetic screening that is accessible to most everyone. Accessed online at: [link]. Piomeli, Daniele (2002). 2002 Feb-Mar;66(2-3):143-60.

Therapy 40

Therapy Cannabinoids Cannabis Terpenes 40

Otherside Farms

JANUARY 23, 2019

Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. Medscape: Medscape Access. Cannabinoids as potential new therapy for the treatment of gliomas. Cannabis as a possible treatment for lung cancer (news – 2007).

Cannabinoids 72

Cannabinoids Treatment Therapy Research and Development 72

The Cannigma

DECEMBER 12, 2022

Turning down activity in the DMN allows better access to new areas of the brain, which can boost creativity and improve problem solving. However, the FDA recently approved a nasal formulation of esketamine (Spravato) which is the S-isomer of ketamine (hence the name) for treatment-resistant depression. Are psychedelics safe?

History 123

History Microdosing Research and Development Clinical Trials 123

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 24, 2021

9-THC, the main psychoactive component in cannabis, rose from about 4 per cent to 16 per cent in the United States over the period 1995–2019, and from about 6 per cent to 11 per cent in Europe over the period 2002–2019. ?9-THC Drug Use Rising, but Science-Based Treatment More Available. According to the Report, the percentage of ?9-THC

Research and Development 99

Research and Development Supply Chain Pharmaceutical Treatment 99

Cannabis Law Report

JANUARY 10, 2020

This continues to create challenges for marijuana businesses, including access to the payment and banking systems. A recent study using the same NSDUH data stated that marijuana use in 12 to 17 year olds in 2002 to 2005 fell from 10.5 Conclusion. The data can be found here: [link]. percent to 9.0 HHS Publication No. Senate review.

Banking 59

Banking Marijuana Collective Recreational 59

Cannabis Law Report

JANUARY 21, 2022

Authority on real estate development and cultivation design, holding a commercial general contractor license since 2002. Founding member of the National Cannabis Industry Association, Lifetime Investor member of the ArcView Group, and sustaining member of Students for Sensible Drug Policy (SSDP) and Americans for Safe Access (ASA).

Research and Development 52

Research and Development Education Advocacy Policy 52

Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. where patients are legally administered ketamine for treatment of mental illness and severe pain.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe. Lyle Craker, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

SpeedWeed

FEBRUARY 21, 2021

Greg Williams began working for Marc Emery’s world-changing “Emery Direct Marijuana Seed Bank” in 1996, when it was nearly impossible for growers to access seeds and a wide range of genetics. His show “So You Wanna Grow Pot” was launched in 2002, and taught thousands of people how to grow marijuana properly.

Marijuana 52

Marijuana Events Access Medicine 52

The Cannigma

JANUARY 3, 2023

Dr. Ethan Russo, a renowned cannabis scientist, published a paper in 2002 detailing historical uses of cannabis in women’s health. Researchers in a 2014 rodent study noted beta-caryophyllene was “highly effective in the treatment of long-lasting, debilitating pain states.”.

Terpenes 110

Terpenes Strains Oil THC 110

Medical Cannabis Seedbank

AUGUST 6, 2018

The government implemented a program aimed at granting access to medical cannabis and later modified this to allow cannabis cultivation for medical use. Cancer patients and those with chronic pain have prescription access to the substance. Now, as a result of complete legalization, this research is sure to grow even further.

Research and Development 61

Research and Development Cultivation Chronic Pain Cannabis 61

SpeedWeed

FEBRUARY 19, 2021

Nunn, 2002). They retted the stems and twisted the fibers into sturdy ropes and ground the plant to make a soothing eyewash, a treatment they recorded in the medical papyri. The Berlin Papyrus (1300 BC) records a topical treatment for swelling: “A remedy to treat inflammation: “Blätter (oder Blüten?) Gebrauch es als Salbe.”

Research and Development 52

Research and Development Cannabis Hemp Concentrates 52

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

The governor of Alabama signed a recreational bill into law in 2021, but patients will likely not have access to retail products until 2022. Allow legitimate cannabis-related businesses to access Small Business Administration (SBA) loans and services. in 2002 to 49.2% of the population, a 200% increase from 2002.

Recreational 52

Recreational Data Cannabis DEA 52

Cannabis Law Report

JANUARY 21, 2019

Track-and-Trace System Reporting Requirements, Section 40513 Track-and-Trace – Loss of Access, Section 40515 Track-and-Trace Temporary Licenses, and Section 40517 Track-and-Trace System – UID Tag Order. All electronic storage systems must provide a complete and accurate record of your data that is accessible to the IRS. .

Seed-To-Sale 40

Seed-To-Sale Business Compliance Compliance 40